Flammang, I.; Reese, M.; Ströse, A.J.; Yang, Z.; Eble, J.A.; Dhayat, S.A.
Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Cancers 2024, 16, 2825.
https://doi.org/10.3390/cancers16162825
AMA Style
Flammang I, Reese M, Ströse AJ, Yang Z, Eble JA, Dhayat SA.
Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Cancers. 2024; 16(16):2825.
https://doi.org/10.3390/cancers16162825
Chicago/Turabian Style
Flammang, Isabelle, Moritz Reese, Anda J. Ströse, Zixuan Yang, Johannes A. Eble, and Sameer A. Dhayat.
2024. "Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693" Cancers 16, no. 16: 2825.
https://doi.org/10.3390/cancers16162825
APA Style
Flammang, I., Reese, M., Ströse, A. J., Yang, Z., Eble, J. A., & Dhayat, S. A.
(2024). Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. Cancers, 16(16), 2825.
https://doi.org/10.3390/cancers16162825